Diagnostic Kits/Legal uncertainty in the area of genetic diagnostic testing: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 2: Line 2:
doi:10.1038/nbt1009-903
doi:10.1038/nbt1009-903
http://www.nature.com/nbt/journal/v27/n10/abs/nbt1009-903.html [accessed Nov 2 2009].
http://www.nature.com/nbt/journal/v27/n10/abs/nbt1009-903.html [accessed Nov 2 2009].
Legal uncertainty in the area of genetic diagnostic testing<br />
Legal uncertainty in the area of genetic diagnostic testing<br />
Isabelle Huys1, Nele Berthels1, Gert Matthijs1 & Geertrui Van Overwalle2
Isabelle Huys1, Nele Berthels1, Gert Matthijs1 & Geertrui Van Overwalle2
Abstract<br>
Abstract<br>
A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.
A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.
=Navigation=
[[Category:Diagnostic_Kits]]
[http://cyber.law.harvard.edu/commonsbasedresearch/Diagnostic_Kits#Resources DK Bibliography]<br>
[[Diagnostic_Kits]]<br>
[[Main Page]]

Latest revision as of 15:41, 4 May 2010

Nature Biotechnology 27, 903 - 909 (2009) doi:10.1038/nbt1009-903 http://www.nature.com/nbt/journal/v27/n10/abs/nbt1009-903.html [accessed Nov 2 2009]. Legal uncertainty in the area of genetic diagnostic testing
Isabelle Huys1, Nele Berthels1, Gert Matthijs1 & Geertrui Van Overwalle2 Abstract
A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.

Navigation

DK Bibliography
Diagnostic_Kits
Main Page